Sir John Bell, a professor at Oxford University in the U.K., told CNBC on Wednesday he was confident that Covid-19 vaccines could be retooled to provide effective protection against future coronavirus mutations. Bell’s comments on “Closing Bell” come as global…
Read MoreTag: Gilead Sciences Inc
‘This is already in the U.S.,’ says Dr. Gottlieb
Former FDA chief Dr. Scott Gottlieb warned that the highly contagious, new mutation of Covid-19 found in the United Kingdom “is already in the U.S.” as more than 40 countries ban travel to and from the U.K. for 48 hours…
Read More
Covid vaccines likely to protect against new virus strain: Dr Gottlieb
Dr. Scott Gottlieb told CNBC on Monday that existing Covid-19 vaccines will likely provide protection against the new strain of the coronavirus circulating in the U.K. British Prime Minister Boris Johnson on Saturday implemented strict lockdowns in London and large parts of…
Read More
Dr. Scott Gottlieb expects shortages to last through next week
Dr. Scott Gottlieb told CNBC on Friday he expects a shortage of Covid-19 vaccine doses to continue past next week, even if the Food and Drug Administration issues emergency use authorization for Moderna’s vaccine. “I’ve talked to hospitals. They’re vaccinating far…
Read More
Relief Therapeutics shares have soared 38,000% in 2020
Medical staff examine a patient in the Covid-19 intensive care unit at United Memorial Medical Center in Houston on Nov. 16, 2020. Go Nakamura | Getty Images LONDON — Swiss biotech firm Relief Therapeutics has seen its share price climb…
Read More
FDA says Pfizer Covid vaccine provides some protection after first dose, meets success criteria
The Food and Drug Administration said Tuesday data from Pfizer’s coronavirus vaccine trials was consistent with recommendations put forth by the agency for an emergency use authorization, adding the vaccine was highly effective and did not raise any specific safety…
Read More
Covid treatment used by Trump authorized by FDA
View of Corporate and Research and Development Headquarters of Regeneron Pharmaceuticals on Old Saw Mill River Road in Tarrytown, New York. Lev Radin | LightRocket | Getty Images The Food and Drug Administration on Saturday granted an emergency use authorization…
Read More
5 things to know before the stock market opens November 20, 2020
Here’s the most important news, trends and analysis that investors need to start their trading day: 1. Investors assess vaccine news against Covid-19 case spikes Pfizer and BioNTech said they’ll apply with the FDA on Friday for emergency use authorization…
Read More
WHO tells doctors don’t use Gilead’s remdesivir, splitting with FDA
A lab technicians shows the coronavirus disease (COVID-19) treatment drug “Remdesivir”. Amr Abdallah Dalsh | Reuters A World Health Organization panel advised doctors Thursday against using Gilead Sciences‘ antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19, saying…
Read More
Bioethicists worry the rich and powerful will get special access to experimental treatments
U.S. President Donald Trump looks over at reporters and photographers as the president departs Walter Reed National Military Medical Center after a fourth day of treatment for the coronavirus disease (COVID-19) to return to the White House in Washington from…
Read More